Silvestro Stephen L — SEC insider filings
SEC reporting owner CIK 1773461. 34 insider filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 34 filings on record, filed 2021-01-11 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 3,200 shares, $50,112 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 9 legs across 9 filings — 107,553 shares, $6,504,572 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 65.
- Largest priced transaction: sale of 13,241 shares @ $85.38 ($1,130,517) in OptimizeRx Corp, filed 2021-10-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OptimizeRx Corp (OPRX) | Chief Executive Officer | 34 | 1 leg · 3,200 sh · $50,112 | 9 legs · 107,553 sh · $6,504,572 | 65 |
Insider filings — Silvestro Stephen L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | OptimizeRx Corp (OPRX) | Tax withholding (F): 1,737 @ $7.71 | EDGAR |
| 2026-08-24 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 79,200 @ $0 | EDGAR |
| 2026-05-18 | 4 | OptimizeRx Corp (OPRX) | Tax withholding (F): 5,219 @ $5.21 | EDGAR |
| 2025-12-23 | 4/A | OptimizeRx Corp (OPRX) | Tax withholding (F): 3,361 @ $12.74 | EDGAR |
| 2025-12-23 | 4 | OptimizeRx Corp (OPRX) | Tax withholding (F): 3,361 @ $12.74 | EDGAR |
| 2025-12-22 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 6,546 @ $0 · Tax withholding (F): 1,594 @ $13.51 · Option exercise (M): 6,546 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 6,649 @ $0 · Sale (S): 1,620 @ $18.75 · Option exercise (M): 6,649 (derivative) @ $0 | EDGAR |
| 2025-08-25 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 15,625 @ $0 · Grant/award (A): 35,156 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 46,948 @ $0 · Grant/award (A): 80,884 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 1,928 @ $0 · Tax withholding (F): 572 @ $5.18 · Option exercise (M): 1,928 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | OptimizeRx Corp (OPRX) | Tax withholding (F): 2,298 @ $6.64 | EDGAR |
| 2024-12-27 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 41,408 @ $0 · Grant/award (A): 77,742 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 6,546 @ $0 · Tax withholding (F): 2,576 @ $4.75 · Option exercise (M): 6,546 (derivative) @ $0 | EDGAR |
| 2024-10-07 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 6,649 @ $0 · Tax withholding (F): 2,617 @ $7.83 · Option exercise (M): 6,649 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4/A | OptimizeRx Corp (OPRX) | Grant/award (A): 7,750 @ $0 | EDGAR |
| 2024-05-06 | 4/A | OptimizeRx Corp (OPRX) | Option exercise (M): 1,927 @ $0 · Tax withholding (F): 572 @ $15.95 | EDGAR |
| 2024-05-06 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 90,000 @ $0 · Tax withholding (F): 35,415 @ $10.70 · Option exercise (M): 90,000 (derivative) @ $0 | EDGAR |
| 2024-04-24 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 7,750 @ $0 | EDGAR |
| 2024-03-06 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 1,927 @ $0 · Tax withholding (F): 668 @ $15.95 · Option exercise (M): 1,927 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 19,639 (derivative) @ $0 · Grant/award (A): 19,639 (derivative) @ $0 | EDGAR |
| 2023-10-06 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 6,649 @ $0 · Tax withholding (F): 1,952 @ $7.06 · Option exercise (M): 6,649 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 1,927 @ $0 · Tax withholding (F): 668 @ $18.11 · Option exercise (M): 1,927 (derivative) @ $0 | EDGAR |
| 2022-10-05 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 19,947 (derivative) @ $0 · Grant/award (A): 39,055 (derivative) @ $0 | EDGAR |
| 2022-08-17 | 4 | OptimizeRx Corp (OPRX) | Purchase (P): 3,200 @ $15.66 | EDGAR |
| 2022-03-03 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 11,726 (derivative) @ $0 · Grant/award (A): 5,782 (derivative) @ $0 | EDGAR |
| 2021-12-21 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 13,241 @ $7.51 · Sale (S): 13,241 @ $54.87 · Option exercise (M): 13,241 (derivative) @ $0 | EDGAR |
| 2021-11-19 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 13,241 @ $7.51 · Sale (S): 13,241 @ $73.98 · Option exercise (M): 13,241 (derivative) @ $0 | EDGAR |
| 2021-10-19 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 13,241 @ $7.51 · Sale (S): 13,241 @ $85.38 · Option exercise (M): 13,241 (derivative) @ $0 | EDGAR |
| 2021-09-21 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 13,242 @ $7.51 · Sale (S): 13,242 @ $69.79 · Option exercise (M): 13,242 (derivative) @ $0 | EDGAR |
| 2021-08-19 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 13,242 @ $7.51 · Sale (S): 13,242 @ $58.41 · Option exercise (M): 13,242 (derivative) @ $0 | EDGAR |
| 2021-07-21 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 13,242 @ $7.51 · Sale (S): 13,242 @ $50.34 · Option exercise (M): 13,242 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 13,242 @ $7.51 · Sale (S): 13,242 @ $53.44 · Option exercise (M): 13,242 (derivative) @ $0 | EDGAR |
| 2021-05-19 | 4 | OptimizeRx Corp (OPRX) | Sale (S): 13,242 @ $42.72 · Option exercise (M): 13,242 @ $7.51 · Option exercise (M): 13,242 (derivative) @ $0 | EDGAR |
| 2021-01-11 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 38,511 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1773461 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs